| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 37,179 | 149,861 | 109,690 | 119,760 | | Cost of Revenue | 33,292 | 269,074 | 97,501 | 105,288 | | | Gross Profit | 3,887 | (119,213) | 12,189 | 14,472 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 9,284 | 20,766 | 16,623 | 15,504 | | Non Recurring | 15,518 | (17,427) | 40,312 | 26,651 | | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (20,915) | (122,552) | (44,746) | (27,683) | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
| 9,030 | | Earnings Before Interest And Taxes | (18,556) | (111,311) | (40,793) | (14,248) | | Interest Expense |
-
|
-
|
-
|
-
| | Income Before Tax | (18,556) | (111,311) | (40,793) | (14,248) | | Income Tax Expense | (6,319) | (42,298) | (15,502) | (5,413) | | Minority Interest |
-
| 10,322 | 3,994 | 2,020 | | | | Net Income From Continuing Ops | (12,237) | (69,013) | (25,291) | (8,835) | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | (12,237) | (69,013) | (25,291) | (8,835) | | Preferred Stock And Other Adjustments | 1,928 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | ($10,309) | ($69,013) | ($25,291) | ($8,835) |
|
0.22% Nasdaq 
Income Statement
